Scynexis (SCYX) Common Equity (2013 - 2026)
Scynexis (SCYX) posted Common Equity of $64000.0 for Q1 2026, up 39.13% on a QoQ basis from $46000.0 in Q4 2025, and down 99.87% year-over-year from $50.5 million in Q1 2025.
Scynexis (SCYX) Common Equity (2013 - 2026) Analysis & Trends
Scynexis' Common Equity history runs 14 years deep, the most recent figure standing at $64000.0 for Q1 2026.
- Quarterly Common Equity fell 99.87% year-over-year to $64000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64000.0 (down 99.87% YoY) and the FY2025 annual result came in at $46000.0, down 99.92% from the prior year.
- Common Equity was $64000.0 for Q1 2026 at Scynexis, up from $46000.0 in the prior quarter.
- Across five years, Common Equity topped out at $93.1 million in Q2 2023 and bottomed at -$29.9 million in Q1 2023.
- A 5-year average of $39.8 million and a median of $45.5 million in 2022 frame the typical range for Common Equity.
- Peak annual rise in Common Equity reached 2156.79% in 2023, while the deepest fall reached 176.85% in 2023.
- Scynexis' Common Equity stood at $3.2 million in 2022, then jumped by 2156.79% to $73.0 million in 2023, then fell by 24.51% to $55.1 million in 2024, then tumbled by 99.92% to $46000.0 in 2025, then soared by 39.13% to $64000.0 in 2026.
- Business Quant data shows SCYX's Common Equity at $64000.0 in Q1 2026, $46000.0 in Q4 2025, and $45000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.93 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.23 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 3.23 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 47.38 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.90 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 56.13 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 3.41 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.50 Bn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | 64,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64,000.00 |
| Dec 31, 2025 | 46,000.00 |
| Sep 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 44.47 Mn |
| Mar 31, 2025 | 50.53 Mn |
| Dec 31, 2024 | 55.08 Mn |
| Sep 30, 2024 | 58.53 Mn |
| Jun 30, 2024 | 60.41 Mn |
| Mar 31, 2024 | 74.11 Mn |
| Dec 31, 2023 | 72.96 Mn |
| Sep 30, 2023 | 91.99 Mn |
| Jun 30, 2023 | 93.08 Mn |
| Mar 31, 2023 | -29.91 Mn |
| Dec 31, 2022 | 3.23 Mn |
| Sep 30, 2022 | 17.21 Mn |
| Jun 30, 2022 | 45.48 Mn |
| Mar 31, 2022 | 38.93 Mn |
| Dec 31, 2021 | 41.26 Mn |
| Sep 30, 2021 | 37.61 Mn |
| Jun 30, 2021 | 32.32 Mn |